High pressure post-dilatation is necessary to optimize deployment of drug-eluting stents for the treatment of in-stent restenosis

High pressure post-dilatation is necessary to optimize deployment of drug-eluting stents for the treatment of in-stent restenosis

Detalhes bibliográficos
Principais autores:	Blackman, D, Porto, I, Channon, K, Banning, A
Formato:	Conference item
Publicado em:	2003

Registros relacionados

Usefulness of high-pressure post-dilatation to optimize deployment of drug-eluting stents for the treatment of diffuse in-stent coronary restenosis.
por: Blackman, D, et al.
Publicado em: (2004)

Use of a sirolimus-eluting stent to treat failure of a nonpolymer release paclitaxel-eluting stent implanted for in-stent restenosis.
por: Porto, I, et al.
Publicado em: (2005)

Intracoronary brachytherapy for in-stent restenosis of drug-eluting stents
por: Nisha Ohri, MD, et al.
Publicado em: (2016-01-01)

Drug-eluting stent in-stent restenosis and re-restenosis: A hard time story
por: Violeta Dinesch, et al.
Publicado em: (2017-04-01)

Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug- Eluting Stents
por: Negar Faramarzi, et al.
Publicado em: (2015-10-01)

Overview of intracoronary brachytherapy for in-stent restenosis of a drug-eluting stent
por: Sohila Refahi, et al.
Publicado em: (2019-03-01)

Risk assessment score for drug eluting stent restenosis
por: Z. A. Gabbasov, et al.
Publicado em: (2018-09-01)

Paclitaxel eluting stents versus bare metal stents restenosis
por: Ronald Aroche Aportela, et al.
Publicado em: (2021-12-01)

Drug-eluting stents or balloon angioplasty for drug-eluting stent-associated restenosis: An observational follow-up study of first-time versus repeated restenosis
por: Mohamed Aboel-Kassem F. Abdelmegid, et al.
Publicado em: (2017-04-01)

Incidence, predictors and management of left main coronary artery stent restenosis: a comprehensive review in the era of drug-eluting stents.
por: De Caterina, A, et al.
Publicado em: (2013)

Comparison of Bare metal Vs Drug eluting stents for in-stent Restenosis among Diabetics
por: Kakhaber Etsadashvili, et al.
Publicado em: (2011-06-01)

Genetic risk model for in-stent restenosis of second-and third-generation drug-eluting stents
por: Yen-Wen Liu, et al.
Publicado em: (2021-09-01)

Classification and patterns of bifurcation in-stent restenosis (BISR) in the second generation drug eluting stent era
por: Omar A. Meelu, MS, et al.
Publicado em: (2017-03-01)

In-stent restenosis of drug-eluting stents: clinical presentation and outcomes in a real-world scenario
por: Ganesh Paramasivam, et al.
Publicado em: (2019-11-01)

Prognostic Role of Fasting Remnant Cholesterol with In-Stent Restenosis After Drug-Eluting Stent Implantation
por: Luo Y, et al.
Publicado em: (2022-02-01)

The sirolimus-eluting Cypher Select coronary stent for the treatment of bare-metal and drug-eluting stent restenosis: insights from the e-SELECT (Multicenter Post-Market Surveillance) registry.
por: Abizaid, A, et al.
Publicado em: (2012)

Caracterización de la restenosis de stents coronarios convencionales y liberadores de medicamentos en pacientes incluidos en el registro DRug Eluting STent (DREST) Characterization of conventional coronary stents restenosis and drug eluting stents in patients included in the Drug Eluting Stent Registry (DREST)
por: Jorge A Arroyave C, et al.
Publicado em: (2012-06-01)

Safety of MRI early after implantation of a drug-eluting stent.
por: Porto, I, et al.
Publicado em: (2004)

Risk Factors and Incidence for In-Stent Restenosis with Drug-Eluting Stent: A Systematic Review and Meta-Analysis
por: Birong Liu, et al.
Publicado em: (2024-12-01)

The Endovascular Therapy for In-Stent Restenosis After Fluoropolymer-Based Drug-Eluting Stent Implantation in Femoropopliteal Lesions
por: Kazunori Horie, MD, et al.
Publicado em: (2025-01-01)

The Predictors of Target Lesion Revascularization and Rate of In-Stent Restenosis in the Second-Generation Drug-Eluting Stent Era
por: Chengbin Zheng, et al.
Publicado em: (2019-01-01)

Coronary In-Stent Restenosis Predictors following Drug-Eluting Stent Implantation: A Meta-Analysis Study
por: Mohammad Saifur Rohman, et al.
Publicado em: (2023-07-01)

In-stent restenosis of drug-eluting stents in patients with diabetes mellitus: Clinical presentation, angiographic features, and outcomes
por: Ganesh Paramasivam, et al.
Publicado em: (2019-12-01)

The Role Of Inflammation In Stent Restenosis More Than 1 Year Afetr Drug Eluting Stent Implantation
por: Hasan Shemirani, et al.
Publicado em: (2011-09-01)

Clinical Outcomes of Drug-Eluting versus Bare-Metal In-Stent Restenosis after the Treatment of Drug-Eluting Stent or Drug-Eluting Balloon: A Systematic Review and Meta-Analysis
por: Yi-Xing Yang, et al.
Publicado em: (2020-01-01)

Recurrent in-stent restenosis with total occlusion remedied with drug-eluting balloon angioplasty
por: Mohd Shah, Azarisman Shah, et al.
Publicado em: (2011)

Do pre-procedural laboratory parameters predict drug-eluting stent restenosis?
por: Aslı Tanındı, et al.
Publicado em: (2015-07-01)

Do pre-procedural laboratory parameters predict drug-eluting stent restenosis?
por: Murat Gençbay
Publicado em: (2015-07-01)

Application of genetic risk score for in-stent restenosis of second- and third-generation drug-eluting stents in geriatric patients
por: Yu-Ling Hsu, et al.
Publicado em: (2023-07-01)

In Stent Restenosis After Drug-Eluting Stent Implantation in a Patient with Polycythemia Vera: A Case Report
por: I Gusti Ayu Ratna Dewi, et al.
Publicado em: (2023-06-01)

The effect of sex differences on neointimal characteristics of in-stent restenosis in drug-eluting stents: An optical coherence tomography study
por: Xiaohang Yuan, et al.
Publicado em: (2023-08-01)

Combining short stent implantation and drug-eluting stenting for routine use yields a low restenosis rate
por: Dauer Cheryl, et al.
Publicado em: (2005-12-01)

Impact of Paclitaxel-Eluting Balloons Compared to Second-Generation Drug-Eluting Stents for of In-Stent Restenosis in a Primarily Acute Coronary Syndrome Population
por: Guillaume Marquis-Gravel, et al.
Publicado em: (2017-09-01)

Focal in-stent restenosis and in-stent thrombosis within the same bare-metal stent 5 years after deployment in a saphenous vein graft.
por: Ponnuthurai, F, et al.
Publicado em: (2007)

Drug-coated balloons versus drug-eluting stents in patients with in-stent restenosis: An updated meta-analysis with trial sequential analysis
por: Ahmed Abdelaziz, et al.
Publicado em: (2024-11-01)

Drug-Eluting Balloons versus Second-Generation Drug-Eluting Stents for Treating In-Stent Restenosis in Coronary Heart Disease after PCI: A Meta-Analysis
por: Wen-Juan Xiu, et al.
Publicado em: (2018-01-01)

Comparison of clinical outcomes after drug-eluting balloon and drug-eluting stent use for in-stent restenosis related acute myocardial infarction: a retrospective study
por: Chih-Yuan Fang, et al.
Publicado em: (2018-04-01)

Long-Term Clinical Outcome after Sirolimus-Stent Implantation for in Sirolimus-Eluting Stent Restenosis
por: Alain Guidon, et al.
Publicado em: (2008-01-01)

Impact of Obstructive Sleep Apnea on In-Stent Restenosis in Coronary Heart Disease Patients after Elective Drug-Eluting Stenting
por: Wenjie Yang, et al.
Publicado em: (2025-01-01)

Risk investigation of in-stent restenosis after initial implantation of intracoronary drug-eluting stent in patients with coronary heart disease
por: Hongfei Xi, et al.
Publicado em: (2023-03-01)